Marinus (MRNS) drops 3.22% in Light Trading on September 29

Shares of Marinus Pharmaceuticals Inc (NASDAQ: MRNS) fell 3.22%, or $ 0.38 per share, to close at $ 11.41 on Wednesday. After opening the day at $ 11.91, Marinus shares have fluctuated between $ 11.93 and $ 11.30. 164,304 shares traded hands down from their 30-day average of 220,042. Wednesday’s activity brought Marinus’ market cap to $ 419,112,519.

About Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapies to treat rare seizure disorders. Ganaxolone is a positive allosteric modulator of GABAA receptors that acts on a well-characterized target in the brain known to have anti-epileptic, anti-depressant and anti-anxiety potential. Ganaxolone is under development as intravenous and oral doses intended to maximize the therapeutic reach of adult and pediatric patient populations in acute and chronic care settings. Marinus recently completed the first-ever pivotal phase 3 trial in children with CDKL5 deficiency disorder and is conducting a phase 3 refractory status epilepticus trial, a phase 2 trial in tuberous sclerosis Bourneville and a phase 2 proof of concept trial on PCDH19. -related to epilepsy.

Visit the Marinus Pharmaceuticals Inc profile for more information.

The daily solution

Athletes vying to represent the United States at the 2022 Olympic Winter Games in Beijing must be vaccinated against COVID-19, the United States Olympic and Paralympic Committee (USOPC) has said.

The Federal Aviation Administration (FAA) wants US airlines to do more to deal with the upsurge in incidents involving unruly or violent passengers.

Beyond Meat Inc’s (Nasdaq: BYND) meatless chicken offerings will be available for purchase in select grocery stores nationwide starting next month, the fake meat company said on Monday.

About the Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, as well as the listing of stocks and options. The Nasdaq is the world’s largest stock exchange for options volume and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information about Marinus Pharmaceuticals Inc and keep up with the latest company updates, you can visit the company profile page here: Marinus Pharmaceuticals Inc. Profile For more financial market information, no. be sure to visit Equities News. Also, don’t forget to sign up for the Daily Fix to get the best stories delivered to your inbox 5 days a week.

Sources: The chart is provided by TradingView on the basis of prices delayed by 15 minutes. All other data provided by IEX Cloud as of 8:05 p.m. ET on the day of publication.

The views and opinions expressed in this article are those of the authors and do not represent the views of Readers should not take the author’s statements as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please visit:

Beyond Meat to launch meatless chicken offerings in grocery stores in October

President Biden welcomes leaders of India, Japan and Australia to first “Quad” summit on Friday

Some Chinese Banks Stop Offering New Loans To Real Estate Developers Amid Evergrande Fear

Iowa Senator Chuck Grassley is running for eighth term

Special House committee assigns four Trump allies in U.S. Capitol riots investigation

CDC approves COVID-19 vaccine booster shots for millions of elderly and vulnerable people

Semiconductor shortage to cost global auto industry $ 210 billion in revenue in 2021

US Olympians to be vaccinated against COVID-19 for Beijing Winter Games

About Michael Bill

Check Also

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency

ClearPoint Neuro, Inc. First gene therapy directly infused into the brain to be delivered with …

Leave a Reply

Your email address will not be published.